Bioness launches clinical trial for StimRouter in overactive bladder

Bioness says 4 patients were successfully implanted with its StimRouter neuromodulation device to treat their overactive bladders.

Bioness last week said it's making progress with a Canadian study of its StimRouter neuromodulation device designed to expand the number of conditions for which it can be used for treatment.

Bioness Inc.

News Well, Clinical Trials, Gynecological, Neuromodulation/Neurostimulation, Urology

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1OQOOiF